Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

ARDX

Ardelyx (ARDX)

Ardelyx Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ARDX
DatumZeitQuelleÜberschriftSymbolFirma
13/03/201500h33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
11/03/201521h56Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARDXArdelyx Inc
11/03/201521h50Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ARDXArdelyx Inc
05/03/201522h12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARDXArdelyx Inc
25/02/201522h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARDXArdelyx Inc
25/02/201522h01PR Newswire (US)Ardelyx Reports Fourth Quarter and Full Year 2014 Financial ResultsNASDAQ:ARDXArdelyx Inc
18/02/201514h00PR Newswire (US)Ardelyx to Report Fourth Quarter and Full Year 2014 Financial Results on February 25th, 2015NASDAQ:ARDXArdelyx Inc
17/02/201522h23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARDXArdelyx Inc
13/02/201516h05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARDXArdelyx Inc
12/02/201522h10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARDXArdelyx Inc
09/02/201523h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARDXArdelyx Inc
09/02/201514h00PR Newswire (US)Ardelyx to Present at the 2015 Leerink Global Healthcare ConferenceNASDAQ:ARDXArdelyx Inc
07/02/201500h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
03/02/201523h34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
02/02/201513h00PR Newswire (US)Ardelyx Reports Results from Phase 2b Clinical Trial Evaluating Tenapanor in Treating Hyperphosphatemia in Chronic Kidney Dis...NASDAQ:ARDXArdelyx Inc
26/01/201520h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARDXArdelyx Inc
12/01/201523h51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
02/01/201522h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
31/12/201422h03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARDXArdelyx Inc
29/12/201423h14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
29/12/201423h14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
29/12/201423h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
29/12/201423h13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
29/12/201423h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
29/12/201423h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
29/12/201423h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
29/12/201423h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARDXArdelyx Inc
18/12/201422h34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ARDXArdelyx Inc
16/12/201421h45Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ARDXArdelyx Inc
01/12/201415h00PR Newswire (US)Ardelyx Appoints Jeremy S. Caldwell, Ph.D., as Executive Vice President and Chief Scientific OfficerNASDAQ:ARDXArdelyx Inc
 Showing the most relevant articles for your search:NASDAQ:ARDX